CN111411161B - Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus - Google Patents

Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus Download PDF

Info

Publication number
CN111411161B
CN111411161B CN202010254527.2A CN202010254527A CN111411161B CN 111411161 B CN111411161 B CN 111411161B CN 202010254527 A CN202010254527 A CN 202010254527A CN 111411161 B CN111411161 B CN 111411161B
Authority
CN
China
Prior art keywords
antigen
seq
detecting
genotyping
peak value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010254527.2A
Other languages
Chinese (zh)
Other versions
CN111411161A (en
Inventor
扈庆华
路琳英
李民旭
姜伊祥
左乐
石晓路
李迎慧
江敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION
Original Assignee
SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION filed Critical SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION
Priority to CN202010254527.2A priority Critical patent/CN111411161B/en
Publication of CN111411161A publication Critical patent/CN111411161A/en
Application granted granted Critical
Publication of CN111411161B publication Critical patent/CN111411161B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a primer group SEQ ID No. 1-SEQ ID No.114 for detecting K antigen genotyping of vibrio parahaemolyticus, wherein the primer group is based on a fluorescent probe melting curve technology of multiple hybridization connection reaction, biological informatics method analysis is carried out according to the whole genome of 418 vibrio parahaemolyticus, 18 specific gene sequences of the vibrio parahaemolyticus in a public database are analyzed, specific genes and specific gene regions of 57K antigens of the vibrio parahaemolyticus are obtained and screened, the primer group is designed aiming at the specific genes of the 57K antigens of the vibrio parahaemolyticus, the primer group can be used for simultaneously detecting the K antigen genotyping of the 57 vibrio parahaemolyticus based on the fluorescent probe melting curve method, and the detection time and the detection accuracy of the antigen genotyping of the vibrio parahaemolyticus are improved.

Description

Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus
Technical Field
The invention relates to the field of biological detection, in particular to a primer group and a kit for detecting K antigen genotyping of vibrio parahaemolyticus.
Background
Vibrio parahaemolyticus, also known as Vibrio enteritis, belongs to the genus Vibrio, gram-negative, facultative anaerobe, is a polymorphous or Vibrio parahaemolyticus, is a common pathogenic bacterium, and is mainly inhabited in seawater. If the seafood polluted by the fungus is eaten, food poisoning is caused, and the seafood is one of main diseases of human beings. Moreover, the vibrio parahaemolyticus is a food-borne pathogenic bacterium with multiple serotypes, and the serotype typing is mainly carried out according to a thallus lipopolysaccharide O antigen and a capsular polysaccharide K antigen of the vibrio parahaemolyticus, wherein the O antigens have 13 types, the K antigens have more than 70 types, and the serotypes are represented by the formula of O: forms of K are shown (e.g., common serotypes O3: K6, O4: K8, etc.).
Currently, the detection method for vibrio parahaemolyticus includes the following aspects: 1. and (3) observation of a hemogram: in the early stage of the disease, the total number of leukocytes is increased to (10-20). times.109L, classifying more than 80% of neutrophils; it is impossible to directly judge whether or not infection occurs. 2. Stool microscopic examination: white blood cells or pus cells are visible, often accompanied by red blood cells, and are easily misdiagnosed as bacillary dysentery. Vibrio parahaemolyticus can be detected by fecal culture, the vast majority rapidly turns negative, and only a few continuously positive for 2-4 days; the antigen genotyping of Vibrio parahaemolyticus cannot be directly detected. 3. And (3) bacterial culture: the disease is developed for 1-2 days, the positive rate of the excrement culture is high, and the positive rate is reduced after 2 days; the detection time is long, and the antigen genotyping of the vibrio parahaemolyticus cannot be directly detected. 4. Serum agglutination test: the serum agglutination titers were high at the early stage of the disease and most of them turned negative soon thereafter. If the titer reaches 1: 80-1: 160, the disease can be diagnosed; the antigen genotyping of Vibrio parahaemolyticus cannot be directly detected. 5. By adopting the common PCR detection, only the infection can be rapidly determined, but the antigen genotyping of the vibrio parahaemolyticus cannot be directly detected.
Because the antigen genotyping quantity of the vibrio parahaemolyticus is large, the detection method adopted at present has the defects of large workload, poor detection accuracy and incapability of quickly and accurately judging the antigen genotyping of the vibrio parahaemolyticus. Therefore, improvements are needed in existing detection methods.
Disclosure of Invention
The invention aims to provide a primer group and a kit for detecting K antigen genotyping of vibrio parahaemolyticus, and aims to solve the problem that the antigen genotyping of the vibrio parahaemolyticus cannot be rapidly and accurately judged in the prior art.
In order to achieve the purpose, the invention adopts the following technical scheme:
a primer group for detecting K antigen genotyping of Vibrio parahaemolyticus, the primer group detects 57K antigen genotyping of Vibrio parahaemolyticus based on a fluorescent probe melting curve method, the primer group comprises:
hybrid connecting primers SEQ ID No.1 and SEQ ID No.2 for detecting K1 antigen genotyping;
hybrid connecting primers SEQ ID No.3 and SEQ ID No.4 for detecting K3 antigen genotyping;
hybrid connecting primers SEQ ID No.5 and SEQ ID No.6 for detecting K4 antigen genotyping;
hybrid connecting primers SEQ ID No.7 and SEQ ID No.8 for detecting K5 antigen genotyping;
hybrid connecting primers SEQ ID No.9 and SEQ ID No.10 for detecting K6 antigen genotyping;
hybrid connecting primers SEQ ID No.11 and SEQ ID No.12 for detecting K7 antigen genotyping;
hybrid connecting primers SEQ ID No.13 and SEQ ID No.14 for detecting K8 antigen genotyping;
hybrid connecting primers SEQ ID No.15 and SEQ ID No.16 for detecting K9 antigen genotyping;
hybrid connecting primers SEQ ID No.17 and SEQ ID No.18 for detecting K11 antigen genotyping;
hybrid connecting primers SEQ ID No.19 and SEQ ID No.20 for detecting K12 antigen genotyping;
hybrid connecting primers SEQ ID No.21 and SEQ ID No.22 for detecting K13 antigen genotyping;
hybrid connecting primers SEQ ID No.23 and SEQ ID No.24 for detecting K15 antigen genotyping;
hybrid connecting primers SEQ ID No.25 and SEQ ID No.26 for detecting K17 antigen genotyping;
hybrid connecting primers SEQ ID No.27 and SEQ ID No.28 for detecting K18 antigen genotyping;
hybrid connecting primers SEQ ID No.29 and SEQ ID No.30 for detecting K19 antigen genotyping;
hybrid connecting primers SEQ ID No.31 and SEQ ID No.32 for detecting K20 antigen genotyping;
hybrid connecting primers SEQ ID No.33 and SEQ ID No.34 for detecting K21 antigen genotyping;
hybrid connecting primers SEQ ID No.35 and SEQ ID No.36 for detecting K22 antigen genotyping;
hybrid connecting primers SEQ ID No.37 and SEQ ID No.38 for detecting K23 antigen genotyping;
hybrid connecting primers SEQ ID No.39 and SEQ ID No.40 for detecting K24 antigen genotyping;
hybrid connecting primers SEQ ID No.41 and SEQ ID No.42 for detecting K25 antigen genotyping;
hybrid connecting primers SEQ ID No.43 and SEQ ID No.44 for detecting K28 antigen genotyping;
hybrid connecting primers SEQ ID No.45 and SEQ ID No.46 for detecting K29 antigen genotyping;
hybrid connecting primers SEQ ID No.47 and SEQ ID No.48 for detecting K30 antigen genotyping;
hybrid connecting primers SEQ ID No.49 and SEQ ID No.50 for detecting K31 antigen genotyping;
hybrid connecting primers SEQ ID No.51 and SEQ ID No.52 for detecting K32 antigen genotyping;
hybrid connecting primers SEQ ID No.53 and SEQ ID No.54 for detecting K33 antigen genotyping;
hybrid connecting primers SEQ ID No.55 and SEQ ID No.56 for detecting K34 antigen genotyping;
hybrid connecting primers SEQ ID No.57 and SEQ ID No.58 for detecting K36 antigen genotyping;
hybrid connecting primers SEQ ID No.59 and SEQ ID No.60 for detecting K37 antigen genotyping;
hybrid connecting primers SEQ ID No.61 and SEQ ID No.62 for detecting K38 antigen genotyping;
hybrid connecting primers SEQ ID No.63 and SEQ ID No.64 for detecting K39 antigen genotyping;
hybrid connecting primers SEQ ID No.65 and SEQ ID No.66 for detecting K40 antigen genotyping;
hybrid connecting primers SEQ ID No.67 and SEQ ID No.68 for detecting K41 antigen genotyping;
hybrid connecting primers SEQ ID No.69 and SEQ ID No.70 for detecting K42 antigen genotyping;
hybrid connecting primers SEQ ID No.71 and SEQ ID No.72 for detecting K43 antigen genotyping;
hybrid connecting primers SEQ ID No.73 and SEQ ID No.74 for detecting K44 antigen genotyping;
hybrid connecting primers SEQ ID No.75 and SEQ ID No.76 for detecting K45 antigen genotyping;
hybrid connecting primers SEQ ID No.77 and SEQ ID No.78 for detecting K46 antigen genotyping;
hybrid connecting primers SEQ ID No.79 and SEQ ID No.80 for detecting K48 antigen genotyping;
hybrid connecting primers SEQ ID No.81 and SEQ ID No.82 for detecting K49 antigen genotyping;
hybrid connecting primers SEQ ID No.83 and SEQ ID No.84 for detecting K51 antigen genotyping;
hybrid connecting primers SEQ ID No.85 and SEQ ID No.86 for detecting K52 antigen genotyping;
hybrid connecting primers SEQ ID No.87 and SEQ ID No.88 for detecting K53 antigen genotyping;
hybrid connecting primers SEQ ID No.89 and SEQ ID No.90 for detecting K54 antigen genotyping;
hybrid connecting primers SEQ ID No.91 and SEQ ID No.92 for detecting K55 antigen genotyping;
hybrid connecting primers SEQ ID No.93 and SEQ ID No.94 for detecting K56 antigen genotyping;
hybrid connecting primers SEQ ID No.95 and SEQ ID No.96 for detecting K59 antigen genotyping;
hybrid connecting primers SEQ ID No.97 and SEQ ID No.98 for detecting K60 antigen genotyping;
hybrid connecting primers SEQ ID No.99 and SEQ ID No.100 for detecting K63 antigen genotyping;
hybrid connecting primers SEQ ID No.101 and SEQ ID No.102 for detecting K64 antigen genotyping;
hybrid connecting primers SEQ ID No.103 and SEQ ID No.104 for detecting K65 antigen genotyping;
hybrid connecting primers SEQ ID No.105 and SEQ ID No.106 for detecting K67 antigen genotyping;
hybrid connecting primers SEQ ID No.107 and SEQ ID No.108 for detecting K68 antigen genotyping;
hybrid connecting primers SEQ ID No.109 and SEQ ID No.110 for detecting K69 antigen genotyping;
hybrid connecting primers SEQ ID No.111 and SEQ ID No.112 for detecting K70 antigen genotyping;
hybrid connecting primers SEQ ID No.113 and SEQ ID No.114 for detecting K71 antigen genotyping.
And a kit for detecting K antigen genotyping of Vibrio parahaemolyticus, the kit comprising the primer set.
And a method for detecting the K antigen genotyping of the vibrio parahaemolyticus, which provides the kit for detecting the K antigen genotyping of the vibrio parahaemolyticus and adopts a fluorescent probe melting curve technology based on multiple hybridization connection reaction to detect the K antigen genotyping of the vibrio parahaemolyticus.
The primer group for detecting K antigen genotyping of vibrio parahaemolyticus provided by the invention is based on a fluorescent probe melting curve technology of multiple hybridization connection reaction, biological informatics method analysis is carried out according to the whole genome of 418 vibrio parahaemolyticus and 18 vibrio parahaemolyticus specific gene sequences in a public database, specific genes and specific gene regions of 57K antigens of vibrio parahaemolyticus are obtained and screened, the obtained specific genes of 57K antigens of vibrio parahaemolyticus are designed, the primer group can be ensured to simultaneously detect the K antigen genotyping of 57 vibrio parahaemolyticus based on the fluorescent probe melting curve method, and the detection time and the detection accuracy of the antigen genotyping of vibrio parahaemolyticus are improved.
The kit provided by the invention contains the primer group, and can be used for rapidly, efficiently and simultaneously detecting the K antigen genotyping of 57 vibrio parahaemolyticus by adopting a fluorescent probe melting curve method, so that the detection time and the detection accuracy of the antigen genotyping of the vibrio parahaemolyticus are improved, the higher sensitivity and the lower cost are ensured, and the kit is favorable for wide application.
The method for detecting the K antigen genotyping of the vibrio parahaemolyticus provided by the invention is characterized in that the kit for detecting the K antigen genotyping of the vibrio parahaemolyticus is utilized, and the fluorescent probe melting curve technology based on multiple hybridization connection reaction is adopted to detect the K antigen genotyping of the vibrio parahaemolyticus. Because the kit contains the primer group, the kit can be used for rapidly, efficiently and simultaneously detecting the K antigen genotyping of 57 vibrio parahaemolyticus by adopting a fluorescent probe melting curve method, so that the detection time and the detection accuracy of the antigen genotyping of the vibrio parahaemolyticus are improved, the higher sensitivity and the lower cost are ensured, and the kit is favorable for wide application.
Drawings
FIG. 1 is a sample Tm graph of a first tube ROX fluorescence channel provided in example 2 of the present invention.
FIG. 2 is a graph showing the Tm of a sample in a Cy5 fluorescence channel of a first tube provided in example 2 of the present invention.
FIG. 3 is a sample Tm graph of a first tube FAM fluorescence channel provided in example 2 of the present invention.
FIG. 4 is a sample Tm graph of a second tube ROX fluorescence channel provided in example 2 of the present invention.
FIG. 5 is a graph showing the Tm of a sample in a Cy5 fluorescence channel of a second tube provided in example 2 of the present invention.
FIG. 6 is a sample Tm graph of a second tube FAM fluorescence channel provided in example 2 of the present invention.
FIG. 7 is a sample Tm graph of a third tube ROX fluorescence channel provided in example 2 of the present invention.
FIG. 8 is a graph showing the sample Tm of the Cy5 fluorescence channel in the third tube provided in example 2 of the present invention.
Detailed Description
In order to make the objects, technical solutions and technical effects of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments obtained by a person of ordinary skill in the art without any inventive step in connection with the embodiments of the present invention shall fall within the scope of protection of the present invention.
In the description of the present invention, it is to be understood that the terms "first", "second" and the like are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implying any number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of the present invention, "a plurality" means two or more unless specifically defined otherwise.
The embodiment of the invention provides a primer group for detecting K antigen genotyping of vibrio parahaemolyticus, the primer group is used for detecting 57 types of K antigen genotyping of vibrio parahaemolyticus based on a fluorescent probe melting curve method, and the primer group comprises:
hybrid connecting primers SEQ ID No.1 and SEQ ID No.2 for detecting K1 antigen genotyping;
hybrid connecting primers SEQ ID No.3 and SEQ ID No.4 for detecting K3 antigen genotyping;
hybrid connecting primers SEQ ID No.5 and SEQ ID No.6 for detecting K4 antigen genotyping;
hybrid connecting primers SEQ ID No.7 and SEQ ID No.8 for detecting K5 antigen genotyping;
hybrid connecting primers SEQ ID No.9 and SEQ ID No.10 for detecting K6 antigen genotyping;
hybrid connecting primers SEQ ID No.11 and SEQ ID No.12 for detecting K7 antigen genotyping;
hybrid connecting primers SEQ ID No.13 and SEQ ID No.14 for detecting K8 antigen genotyping;
hybrid connecting primers SEQ ID No.15 and SEQ ID No.16 for detecting K9 antigen genotyping;
hybrid connecting primers SEQ ID No.17 and SEQ ID No.18 for detecting K11 antigen genotyping;
hybrid connecting primers SEQ ID No.19 and SEQ ID No.20 for detecting K12 antigen genotyping;
hybrid connecting primers SEQ ID No.21 and SEQ ID No.22 for detecting K13 antigen genotyping;
hybrid connecting primers SEQ ID No.23 and SEQ ID No.24 for detecting K15 antigen genotyping;
hybrid connecting primers SEQ ID No.25 and SEQ ID No.26 for detecting K17 antigen genotyping;
hybrid connecting primers SEQ ID No.27 and SEQ ID No.28 for detecting K18 antigen genotyping;
hybrid connecting primers SEQ ID No.29 and SEQ ID No.30 for detecting K19 antigen genotyping;
hybrid connecting primers SEQ ID No.31 and SEQ ID No.32 for detecting K20 antigen genotyping;
hybrid connecting primers SEQ ID No.33 and SEQ ID No.34 for detecting K21 antigen genotyping;
hybrid connecting primers SEQ ID No.35 and SEQ ID No.36 for detecting K22 antigen genotyping;
hybrid connecting primers SEQ ID No.37 and SEQ ID No.38 for detecting K23 antigen genotyping;
hybrid connecting primers SEQ ID No.39 and SEQ ID No.40 for detecting K24 antigen genotyping;
hybrid connecting primers SEQ ID No.41 and SEQ ID No.42 for detecting K25 antigen genotyping;
hybrid connecting primers SEQ ID No.43 and SEQ ID No.44 for detecting K28 antigen genotyping;
hybrid connecting primers SEQ ID No.45 and SEQ ID No.46 for detecting K29 antigen genotyping;
hybrid connecting primers SEQ ID No.47 and SEQ ID No.48 for detecting K30 antigen genotyping;
hybrid connecting primers SEQ ID No.49 and SEQ ID No.50 for detecting K31 antigen genotyping;
hybrid connecting primers SEQ ID No.51 and SEQ ID No.52 for detecting K32 antigen genotyping;
hybrid connecting primers SEQ ID No.53 and SEQ ID No.54 for detecting K33 antigen genotyping;
hybrid connecting primers SEQ ID No.55 and SEQ ID No.56 for detecting K34 antigen genotyping;
hybrid connecting primers SEQ ID No.57 and SEQ ID No.58 for detecting K36 antigen genotyping;
hybrid connecting primers SEQ ID No.59 and SEQ ID No.60 for detecting K37 antigen genotyping;
hybrid connecting primers SEQ ID No.61 and SEQ ID No.62 for detecting K38 antigen genotyping;
hybrid connecting primers SEQ ID No.63 and SEQ ID No.64 for detecting K39 antigen genotyping;
hybrid connecting primers SEQ ID No.65 and SEQ ID No.66 for detecting K40 antigen genotyping;
hybrid connecting primers SEQ ID No.67 and SEQ ID No.68 for detecting K41 antigen genotyping;
hybrid connecting primers SEQ ID No.69 and SEQ ID No.70 for detecting K42 antigen genotyping;
hybrid connecting primers SEQ ID No.71 and SEQ ID No.72 for detecting K43 antigen genotyping;
hybrid connecting primers SEQ ID No.73 and SEQ ID No.74 for detecting K44 antigen genotyping;
hybrid connecting primers SEQ ID No.75 and SEQ ID No.76 for detecting K45 antigen genotyping;
hybrid connecting primers SEQ ID No.77 and SEQ ID No.78 for detecting K46 antigen genotyping;
hybrid connecting primers SEQ ID No.79 and SEQ ID No.80 for detecting K48 antigen genotyping;
hybrid connecting primers SEQ ID No.81 and SEQ ID No.82 for detecting K49 antigen genotyping;
hybrid connecting primers SEQ ID No.83 and SEQ ID No.84 for detecting K51 antigen genotyping;
hybrid connecting primers SEQ ID No.85 and SEQ ID No.86 for detecting K52 antigen genotyping;
hybrid connecting primers SEQ ID No.87 and SEQ ID No.88 for detecting K53 antigen genotyping;
hybrid connecting primers SEQ ID No.89 and SEQ ID No.90 for detecting K54 antigen genotyping;
hybrid connecting primers SEQ ID No.91 and SEQ ID No.92 for detecting K55 antigen genotyping;
hybrid connecting primers SEQ ID No.93 and SEQ ID No.94 for detecting K56 antigen genotyping;
hybrid connecting primers SEQ ID No.95 and SEQ ID No.96 for detecting K59 antigen genotyping;
hybrid connecting primers SEQ ID No.97 and SEQ ID No.98 for detecting K60 antigen genotyping;
hybrid connecting primers SEQ ID No.99 and SEQ ID No.100 for detecting K63 antigen genotyping;
hybrid connecting primers SEQ ID No.101 and SEQ ID No.102 for detecting K64 antigen genotyping;
hybrid connecting primers SEQ ID No.103 and SEQ ID No.104 for detecting K65 antigen genotyping;
hybrid connecting primers SEQ ID No.105 and SEQ ID No.106 for detecting K67 antigen genotyping;
hybrid connecting primers SEQ ID No.107 and SEQ ID No.108 for detecting K68 antigen genotyping;
hybrid connecting primers SEQ ID No.109 and SEQ ID No.110 for detecting K69 antigen genotyping;
hybrid connecting primers SEQ ID No.111 and SEQ ID No.112 for detecting K70 antigen genotyping;
hybrid connecting primers SEQ ID No.113 and SEQ ID No.114 for detecting K71 antigen genotyping.
The primer group for detecting K antigen genotyping of vibrio parahaemolyticus provided by the invention is based on a fluorescent probe melting curve technology of multiple hybridization connection reaction, biological informatics method analysis is carried out according to the whole genome of 418 vibrio parahaemolyticus and 18 vibrio parahaemolyticus specific gene sequences in a public database, specific genes and specific gene regions of 57K antigens of vibrio parahaemolyticus are obtained and screened, the obtained specific genes of 57K antigens of vibrio parahaemolyticus are designed, the primer group can be ensured to simultaneously detect the K antigen genotyping of 57 vibrio parahaemolyticus based on the fluorescent probe melting curve method, and the detection time and the detection accuracy of the antigen genotyping of vibrio parahaemolyticus are improved.
Specifically, according to the bioinformatics method analysis of the 418 strains of vibrio parahaemolyticus whole genome and the 18 strains of vibrio parahaemolyticus specific gene sequence analysis in the public database, the specific names of the specific genes of the 57K antigens of vibrio parahaemolyticus obtained and screened are shown in the following table 1, and the 57K antigens correspond to the 57 specific genes.
Further, the present example was conducted to examine the K antigen genotyping of 57 Vibrio parahaemolyticus. On the basis of the specific genes of 57K antigens of vibrio parahaemolyticus disclosed in table 1, the primers for hybrid ligation described by SEQ ID No. 1-SEQ ID No.114 are designed, and 57 pairs of primer pairs for hybrid ligation are designed in total. The design of the primer sequence of the 57 pairs of hybridization connection primer pairs comprises the following steps: according to 418 strains of vibrio parahaemolyticus whole genome carry out bioinformatics method analysis and search 18 strains of vibrio parahaemolyticus specific genome sequences from NCBI database, finally 57 specific vibrio parahaemolyticus K antigen gene sequences are obtained by analysis, and the 57 specific vibrio parahaemolyticus K antigen gene sequences are compared and analyzed, thereby ensuring that no cross is generated with other bacteria genome. Aiming at the 57 specific vibrio parahaemolyticus K antigen gene sequences, a plurality of pairs of hybridization connecting primers are respectively designed and screened, and the primers with higher Tm peak value and no non-specific peak generated in PCR amplification reaction are obtained by screening. In the invention, because 57 pairs of hybridization connecting primers need to be reasonably distributed into 3 tubes and mixed for testing, interference does not occur in the detection process between the hybridization connecting primers mixed into one tube, and meanwhile, the corresponding antigen genes need to be specifically amplified. The embodiment of the invention is continuously optimized, and the 57 pairs of hybridization connection primer pairs are obtained by screening, so that the 57 types of vibrio parahaemolyticus K antigen genotyping can be simultaneously detected through a three-tube test, and the detection speed and the accuracy are high.
Specifically, the 57 pairs of hybrid ligation primer pairs comprise an upstream hybrid ligation primer and a downstream hybrid ligation primer. Further, the primer sequence structure of the upstream hybridization connecting primer comprises four parts, and the four parts sequentially comprise a universal primer upstream sequence (P1), a spacing sequence (S), a melting point temperature tag sequence (Tm tag) and an upstream hybridization recognition sequence (H1) from the 5' end; wherein the universal upstream primer sequence is used for amplifying the whole primer; the spacer sequence is used for connecting the universal upstream primer sequence and the melting point temperature label sequence; the melting point temperature label sequence is used for hybridizing with the corresponding fluorescent probe and generating a corresponding Tm value; the upstream hybridization recognition sequence is an upstream hybridization recognition sequence that hybridizes to a specific antigen gene to be detected. The primer sequence result of the downstream hybridization connecting primer comprises two parts, namely a downstream hybridization recognition sequence (H2) and a downstream universal primer (P2) from the 5' end; the downstream hybrid recognition sequence is a downstream hybrid recognition sequence hybridized with the specific antigen gene to be detected, the sequence and the upstream hybrid recognition sequence finally form a completely complementary sequence segment with the specific antigen gene to be detected, and the downstream universal primer is used for amplifying the whole primer. Specifically, the specific sequences of the primer sets for detecting the K antigen genotyping of 57 Vibrio parahaemolyticus based on the fluorescent probe melting curve method are shown in Table 2. In the embodiment of the invention, in order to ensure that the 57 vibrio parahaemolyticus K antigen genotypes are detected simultaneously and that the nonspecific amplification does not occur in the test process, the 57 vibrio parahaemolyticus K antigen genotypes are divided into three tubes. Wherein, the 1 st tube comprises a hybridization connecting primer of twenty one antigen genotyping of K70, K68, K17, K56, K29, K25, K8, K6, K18, K42, K44, K5, K60, K11, K41, K12, K28, K13, K9, K36 and K3; the 2 nd tube comprises a hybridization connecting primer of twenty-one antigen genotyping of K1, K4, K19, K20, K55, K63, K34, K65, K49, K48, K30, K21, K67, K69, K71, K38, K37, K33, K32, K31 and K23; the 3 rd tube comprises fifteen hybrid connecting primers for genotyping of K39, K22, K15, K45, K40, K43, K24, K7, K54, K59, K46, K51, K52, K64 and K53 antigens.
Preferably, the primer set further comprises a melting point temperature tag, wherein the melting point temperature tag is a sequence component in the upstream primer design and is used for hybridizing with a corresponding fluorescent probe and generating a corresponding Tm value. Wherein the melting point temperature label is selected from any one of a ROX channel melting point temperature label, a Cy5 channel melting point temperature label and a FAM channel melting point temperature label. Different melting point temperature labels of different channels correspond to different Tm temperature values, so that a plurality of different melting point temperature labels are arranged, and the K antigen genotyping of vibrio parahaemolyticus can be specifically detected.
Further preferably, as shown in Table 3, the ROX channel melting point temperature tags include ROX-1 melting point temperature tag, ROX-2 melting point temperature tag, ROX-3 melting point temperature tag, ROX-4 melting point temperature tag, ROX-5 melting point temperature tag, ROX-6 melting point temperature tag, ROX-7 melting point temperature tag and ROX-8 melting point temperature tag, wherein the sequence of the ROX-1 melting point temperature tag is shown in SEQ ID No.115, the sequence of the ROX-2 melting point temperature tag is shown in SEQ ID No.116, the sequence of the ROX-3 melting point temperature tag is shown in SEQ ID No.117, the sequence of the ROX-4 melting point temperature tag is shown in SEQ ID No.118, the sequence of the ROX-5 melting point temperature tag is shown in SEQ ID No.119, and the sequence of the ROX-6 melting point temperature tag is shown in SEQ ID No.120, The sequence of the ROX-7 melting point temperature label is shown as SEQ ID No.121, and the sequence of the ROX-8 melting point temperature label is shown as SEQ ID No. 122.
More preferably, as shown in Table 3, the Cy5 melting point temperature tags include Cy5-1 melting point temperature tag, Cy5-2 melting point temperature tag, Cy5-3 melting point temperature tag, Cy5-4 melting point temperature tag, Cy5-5 melting point temperature tag, Cy5-6 melting point temperature tag, and Cy5-7 melting point temperature tag, wherein the sequence of the Cy5-1 melting point temperature tag is shown in SEQ ID No.123, the sequence of the Cy5-2 melting point temperature tag is shown in SEQ ID No.124, the sequence of the Cy5-3 melting point temperature tag is shown in SEQ ID No.125, the sequence of the Cy5-4 melting point temperature tag is shown in SEQ ID No.126, the sequence of the Cy5-5 melting point temperature tag is shown in SEQ ID No.127, and the sequence of the Cy5-6 melting point temperature tag is shown in SEQ ID No.128, The sequence of the Cy5-7 melting point temperature label is shown in SEQ ID No. 129.
Further preferably, as shown in table 3, the FAM melting point temperature labels include a FAM-1 melting point temperature label, a FAM-2 melting point temperature label, a FAM-3 melting point temperature label, a FAM-4 melting point temperature label, a FAM-5 melting point temperature label, and a FAM-6 melting point temperature label, wherein the sequence of the FAM-1 melting point temperature label is shown as SEQ ID No.130, the sequence of the FAM-2 melting point temperature label is shown as SEQ ID No.131, the sequence of the FAM-3 melting point temperature label is shown as SEQ ID No.132, the sequence of the FAM-4 melting point temperature label is shown as SEQ ID No.133, the sequence of the FAM-5 melting point temperature label is shown as SEQ ID No.134, and the sequence of the FAM-6 melting point temperature label is shown as SEQ ID No. 135.
In the invention, the technical principle of detecting by adopting the primer group based on a fluorescent probe melting curve method is as follows: firstly, carrying out hybridization reaction, so that each pair of upstream hybridization connecting primer and downstream hybridization connecting primer successfully identifies two continuous specific sequences of the same target gene respectively; secondly, performing ligation reaction to connect each pair of upstream hybrid ligation primers and downstream hybrid ligation primers into a whole under the action of specific ligase, and using the integrated primer as a template in the subsequent step; thirdly, performing a fluorescent probe melting curve method PCR amplification reaction, and performing amplification by using the hybridization connecting product as a template, wherein the universal primer can amplify the hybridization connecting product, and the fluorescent probe can be hybridized with the amplification product of the connecting product; and finally, carrying out fluorescence analysis reaction by a fluorescence probe melting curve method, correspondingly analyzing the collected fluorescence signals to obtain a Tm value, and detecting according to signal peaks of different Tm values to obtain the specific vibrio parahaemolyticus K antigen genotyping.
TABLE 1
Figure BDA0002436776960000081
Figure BDA0002436776960000091
Figure BDA0002436776960000101
TABLE 2
Figure BDA0002436776960000102
Figure BDA0002436776960000111
Figure BDA0002436776960000121
Figure BDA0002436776960000131
Figure BDA0002436776960000141
Figure BDA0002436776960000151
Figure BDA0002436776960000161
Figure BDA0002436776960000171
TABLE 3
Figure BDA0002436776960000172
The invention also provides a kit for detecting the K antigen genotyping of the vibrio parahaemolyticus, and the kit comprises the primer group. The kit provided by the invention contains the primer group, and can be used for rapidly, efficiently and simultaneously detecting the K antigen genotyping of 57 vibrio parahaemolyticus by adopting a fluorescent probe melting curve method, so that the detection time and the detection accuracy of the antigen genotyping of the vibrio parahaemolyticus are improved, the higher sensitivity and the lower cost are ensured, and the kit is favorable for wide application.
Preferably, the kit further comprises ligase and a ligase buffer; wherein the primer set, the ligase, and the ligase buffer are used for a hybridization ligation reaction.
Preferably, the kit further comprises PCR buffer solution and MgCl2dNTP, rTaq enzyme, upstream and downstream universal primers and a fluorescent probe; wherein, the PCR buffer solution and the MgCl2The dNTP, the rTaq enzyme, the upstream and downstream universal primers and the fluorescent probe are used for a detection reaction of a fluorescent probe melting curve method.
Preferably, as shown in Table 4, the upstream universal primer (F) is SEQ ID No.136, and the primer sequence thereof is 5'-GTGGCAGGGCGCTACGAACAAT-3'; the downstream universal primer (R) is SEQ ID No.137, and the primer sequence is 5'-GCCCAGCAAGATCCAATCTCA-3'.
Preferably, the fluorescent probe is any one selected from the group consisting of a ROX fluorescent probe, a Cy5 fluorescent probe, and a FAM fluorescent probe. The fluorescent probe is a sequence used for combining with a melting point temperature label sequence in an upstream primer in the process of probe melting curve reaction. Further preferably, as shown in Table 4, the ROX fluorescent probe is SEQ ID No.138, and the sequence (5 '-3') thereof is ROX-ACGACTCTGGCTGCTCGTTCGTGACG-BHQ 2; the FAM fluorescent probe is SEQ ID No.139, and the sequence (5 '-3') of the FAM fluorescent probe is FAM-TCGGTCCTTCATCGCTCAGCCTTCACCGG-BHQ 1; the Cy5 fluorescent probe is SEQ ID No.140, and the sequence (5 '-3') thereof is Cy5-CGGTGAGGCCCTTGGCAGGTTGCTATCACCC-BHQ 2.
TABLE 4
Figure BDA0002436776960000181
Correspondingly, the invention also provides a method for detecting the K antigen genotyping of the vibrio parahaemolyticus, provides a kit for detecting the K antigen genotyping of the vibrio parahaemolyticus, and detects the K antigen genotyping of the vibrio parahaemolyticus by adopting a fluorescent probe melting curve technology based on multiple hybridization connection reaction.
The method for detecting the K antigen genotyping of the vibrio parahaemolyticus provided by the invention is characterized in that the kit for detecting the K antigen genotyping of the vibrio parahaemolyticus is utilized, and the fluorescent probe melting curve technology based on multiple hybridization connection reaction is adopted to detect the K antigen genotyping of the vibrio parahaemolyticus. Because the kit contains the primer group, the kit can be used for rapidly, efficiently and simultaneously detecting the K antigen genotyping of 57 vibrio parahaemolyticus by adopting a fluorescent probe melting curve method, so that the detection time and the detection accuracy of the antigen genotyping of the vibrio parahaemolyticus are improved, the higher sensitivity and the lower cost are ensured, and the kit is favorable for wide application.
Preferably, the method for detecting the K antigen genotyping of the vibrio parahaemolyticus sequentially comprises a hybridization connection reaction and a fluorescence probe melting curve method detection reaction, and further preferably, the fluorescence probe melting curve method detection reaction sequentially comprises a fluorescence probe melting curve method PCR amplification reaction and then a fluorescence probe melting curve method fluorescence analysis reaction.
Preferably, the hybridization ligation reaction comprises the following steps:
s01, mixing the primer group solution with a vibrio parahaemolyticus DNA template, and performing first denaturation treatment to obtain a primer group mixed solution;
and S02, mixing the primer group mixed solution with the ligase and the ligase buffer solution, and carrying out hybridization and ligation reaction to obtain a hybridization and ligation product.
In the above step S01, the primer set solution is mixed with the Vibrio parahaemolyticus DNA template, and a first denaturation treatment is performed to obtain a primer set mixture. Preferably, the primer set synthesized is dissolved to obtain a mother liquor with a concentration of 5. mu. mol/L, and further diluted to obtain a primer set solution with an initial concentration of 10nmol/L for testing.
In a preferred embodiment of the present invention, in the step of mixing the primer set solution with the Vibrio parahaemolyticus DNA template, the amount of the primer set solution added is 1.5 uL; the addition amount of the vibrio parahaemolyticus DNA template is 5 uL; after mixing at the above-mentioned addition amount, the first denaturation treatment is performed. More preferably, in the step of performing the first denaturing treatment to obtain the primer set mixture, the conditions of the first denaturing treatment are as follows: denaturation at 95 ℃ for 5 min and pausing at 75 ℃ (take out and add 3.5uL of the hybridization ligation reaction).
In step S02, the primer set mixture is mixed with the ligase and the ligase buffer solution, and a hybrid ligation reaction is performed to obtain a hybrid ligation product. Preferably, the reaction system is as follows: 3.5uL of the hybridization ligation reaction solution, including 1. mu.L of ligase with a unit of 1U/. mu.L, 1. mu.L of ligase buffer solution, and 1.5. mu.L of ultrapure water. Further preferably, in the step of performing a hybrid ligation reaction to obtain a hybrid ligation product, the conditions of the hybrid ligation reaction are as follows: ligation was carried out at 60 ℃ for 60 minutes, denaturation was carried out at 95 ℃ for 5 minutes, and the cells were stored at 4 ℃.
Further, the prepared hybrid ligation product is used as a template to carry out the detection reaction of the fluorescent probe melting curve method.
Preferably, the fluorescence probe melting curve method detection reaction comprises performing fluorescence probe melting curve method PCR amplification reaction, and then performing fluorescence analysis reaction by fluorescence probe melting curve method.
Further preferably, the reaction system of the fluorescence probe melting curve method detection reaction is as follows:
TABLE 5
Figure BDA0002436776960000191
Further, the fluorescent probe melting curve method detection reaction comprises a fluorescent probe melting curve method PCR amplification reaction, and then a fluorescent probe melting curve method fluorescence analysis reaction. In a preferred embodiment of the present invention, the conditions for performing the fluorescence probe melting curve PCR amplification reaction are as follows: pre-denaturation at 95 ℃ for 3 min, denaturation at 95 ℃ for 10 sec, annealing at 57 ℃ for 20 sec, extension at 72 ℃ for 20 sec, 38 cycles of reaction set up, and fluorescence signals of ROX, Cy5, FAM were collected at 57 ℃. Further, after performing a fluorescence probe melting curve method PCR amplification reaction, performing a fluorescence analysis reaction by a fluorescence probe melting curve method, wherein the conditions for performing the fluorescence analysis reaction by the fluorescence probe melting curve method are as follows: denaturation at 95 ℃ for 1 min, hybridization at 40 ℃ for 2 min, gradual temperature rise from 40 ℃ to 85 ℃, and collection of fluorescence signals of ROX, Cy5, FAM, wherein the fluorescence signals are collected at 0.5 ℃ per rise from 40 ℃ to 85 ℃.
The following will explain the present invention by way of specific examples.
Example 1
Primer set design
Designing primer sequences of SEQ ID No.1 to SEQ ID No.114 in the above Table 2 according to the specific genes of 57K antigens of Vibrio parahaemolyticus provided in the above Table 1, wherein the primer sequences include fluorescent probes of SEQ ID No.115 to SEQ ID No.135 in the above Table 3; obtaining a primer group for detecting K antigen genotyping of vibrio parahaemolyticus.
Example 2
Detection of K antigen genotyping of 57 vibrio parahaemolyticus
Genotyping 57 vibrio parahaemolyticus K antigens into 3 tubes, and simultaneously carrying out detection in the following steps; wherein, the 1 st tube comprises a hybridization connecting primer of twenty one antigen genotyping of K70, K68, K17, K56, K29, K25, K8, K6, K18, K42, K44, K5, K60, K11, K41, K12, K28, K13, K9, K36 and K3; the 2 nd tube comprises a hybridization connecting primer of twenty-one antigen genotyping of K1, K4, K19, K20, K55, K63, K34, K65, K49, K48, K30, K21, K67, K69, K71, K38, K37, K33, K32, K31 and K23; the 3 rd tube comprises fifteen hybrid connecting primers for genotyping of K39, K22, K15, K45, K40, K43, K24, K7, K54, K59, K46, K51, K52, K64 and K53 antigens.
(1) Performing a hybridization ligation reaction
And mixing the primer group solution with a vibrio parahaemolyticus DNA template, and performing first denaturation treatment to obtain a primer group mixed solution. Wherein the reaction system comprises the following steps: the addition amount of the primer group solution is 1.5uL, and the addition amount of the vibrio parahaemolyticus DNA template is 5 uL; the reaction conditions were as follows: denaturation at 95 ℃ for 5 min and pausing at 75 ℃ (take out and add 3.5uL of the hybridization ligation reaction). And mixing the primer group mixed solution with the ligase and the ligase buffer solution, and carrying out hybridization ligation reaction to obtain a hybridization ligation product. Wherein the reaction system comprises the following steps: 3.5uL of hybridization ligation reaction solution, which comprises 1 uL of ligase with the unit of 1U/uL, 1 uL of ligase buffer solution and 1.5uL of ultrapure water; the reaction conditions were as follows: ligation was carried out at 60 ℃ for 60 minutes, denaturation was carried out at 95 ℃ for 5 minutes, and the cells were stored at 4 ℃.
(2) Performing PCR amplification reaction by fluorescence probe melting curve method
The reaction system of the fluorescence probe melting curve method detection reaction is as shown in table 5, and the reagents are mixed in sequence for reaction, wherein the reaction conditions are as follows: pre-denaturation at 95 ℃ for 3 min, denaturation at 95 ℃ for 10 sec, annealing at 57 ℃ for 20 sec, extension at 72 ℃ for 20 sec, 38 cycles of reaction set up, and fluorescence signals of ROX, Cy5, FAM were collected at 57 ℃.
TABLE 5
Figure BDA0002436776960000211
(3) And carrying out fluorescence analysis reaction by a fluorescence probe melting curve method. Wherein the conditions for performing the fluorescence analysis reaction by the fluorescence probe melting curve method are as follows: denaturation at 95 ℃ for 1 min, hybridization at 40 ℃ for 2 min, gradual temperature rise from 40 ℃ to 85 ℃, and collection of fluorescence signals of ROX, Cy5, FAM, wherein the fluorescence signals are collected at 0.5 ℃ per rise from 40 ℃ to 85 ℃.
Example 3
Evaluation of methodology
488 clinical strains were selected and tested by the method for detecting K antigen genotyping of 57 Vibrio parahaemolyticus of example 2, and the sensitivity and specificity of the method for detecting K antigen genotyping of 57 Vibrio parahaemolyticus of example 2 were examined by analyzing the same by conventional serum methods.
Analysis of results
Example 2 analysis of results
Analysis of the data from the first tube, as shown in table 6 below, from fig. 1, the Tm temperature peak for the K70 antigen was 50.5 ℃, the Tm temperature peak for the K68 antigen was 54.0 ℃, the Tm temperature peak for the K17 antigen was 57.5 ℃, the Tm temperature peak for the K56 antigen was 60.0 ℃, the Tm temperature peak for the K29 antigen was 63.5 ℃, the Tm temperature peak for the K25 antigen was 66.5 ℃, the Tm temperature peak for the K8 antigen was 70.0 ℃, and the Tm temperature peak for the K6 antigen was 74.5 ℃ in the first tube ROX fluorescence channel (NTC is negative control); as can be seen from fig. 2, in the Cy5 fluorescence channel of the first tube (NTC is negative control), the Tm temperature peak of K18 antigen was 53.5 ℃, the Tm temperature peak of K42 antigen was 56.0 ℃, the Tm temperature peak of K44 antigen was 58.5 ℃, the Tm temperature peak of K5 antigen was 61.0 ℃, the Tm temperature peak of K60 antigen was 66.0 ℃, the Tm temperature peak of K11 antigen was 70.5 ℃, and the Tm temperature peak of K41 antigen was 74.0 ℃; as can be seen from fig. 3, in the first tube FAM fluorescence channel (NTC is negative control), the Tm temperature peak of K12 antigen is 51.0 ℃, the Tm temperature peak of K28 antigen is 57.0 ℃, the Tm temperature peak of K13 antigen is 61.5 ℃, the Tm temperature peak of K9 antigen is 66.0 ℃, the Tm temperature peak of K36 antigen is 70.0 ℃, and the Tm temperature peak of K3 antigen is 74.5 ℃.
TABLE 6
Figure BDA0002436776960000221
Analysis of the data of the second tube, as shown in table 7 below, from fig. 4, it can be seen that, in the second tube ROX fluorescence channel (NTC is negative control), the Tm temperature peak of K1 antigen was 51.0 ℃, the Tm temperature peak of K4 antigen was 54.0 ℃, the Tm temperature peak of K19 antigen was 57.0 ℃, the Tm temperature peak of K20 antigen was 59.0 ℃, the Tm temperature peak of K55 antigen was 62.5 ℃, the Tm temperature peak of K63 antigen was 66.5 ℃, the Tm temperature peak of K34 antigen was 70.0 ℃, and the Tm temperature peak of K65 antigen was 73.5 ℃; as can be seen from fig. 5, in the Cy5 fluorescence channel of the second tube (NTC is negative control), the Tm temperature peak of K49 antigen was 50.5 ℃, the Tm temperature peak of K48 antigen was 55.5 ℃, the Tm temperature peak of K30 antigen was 58.5 ℃, the Tm temperature peak of K21 antigen was 61.5 ℃, the Tm temperature peak of K67 antigen was 66.0 ℃, the Tm temperature peak of K69 antigen was 70.5 ℃, and the Tm temperature peak of K71 antigen was 74.5 ℃; as can be seen from fig. 6, in the second tube FAM fluorescence channel (NTC as negative control), the Tm temperature peak of the K38 antigen was 52.0 ℃, the Tm temperature peak of the K37 antigen was 57.0 ℃, the Tm temperature peak of the K33 antigen was 61.0 ℃, the Tm temperature peak of the K32 antigen was 65.5 ℃, the Tm temperature peak of the K31 antigen was 69.5 ℃, and the Tm temperature peak of the K23 antigen was 74.0 ℃.
TABLE 7
Figure BDA0002436776960000222
Figure BDA0002436776960000231
Analysis of the data of the third tube, as shown in table 8 below, from fig. 7, it can be seen that, in the ROX fluorescence channel of the third tube (NTC is negative control), the Tm temperature peak of the K39 antigen is 50.5 ℃, the Tm temperature peak of the K22 antigen is 54.0 ℃, the Tm temperature peak of the K15 antigen is 57.0 ℃, the Tm temperature peak of the K45 antigen is 59.0 ℃, the Tm temperature peak of the K40 antigen is 62.5 ℃, the Tm temperature peak of the K43 antigen is 66.5 ℃, the Tm temperature peak of the K24 antigen is 70.0 ℃, and the Tm temperature peak of the K7 antigen is 74.0 ℃; as can be seen from fig. 8, in the third tube Cy5 fluorescence channel (NTC is negative control), the Tm temperature peak value of K54 antigen was 53.0 ℃, the Tm temperature peak value of K59 antigen was 56.0 ℃, the Tm temperature peak value of K46 antigen was 58.5 ℃, the Tm temperature peak value of K51 antigen was 61.5 ℃, the Tm temperature peak value of K52 antigen was 66.0 ℃, the Tm temperature peak value of K64 antigen was 70.5 ℃, and the Tm temperature peak value of K53 antigen was 74.0 ℃.
TABLE 8
Figure BDA0002436776960000232
Further, the lowest detection limits of the first tube, the second tube and the third tube are analyzed, specifically, as shown in table 9, the lowest detection limit of the first tube is 0.1-1.0 ng/μ L; as shown in Table 10, the minimum detection limit of the second tube was 0.1 to 1.0 ng/. mu.L; as shown in Table 11, the lowest detection limit of the third tube was 0.1 ng/. mu.L; namely, the detection capability level of the method shown in the embodiment 2 is 0.1 to 1.0 ng/. mu.L.
TABLE 9
Figure BDA0002436776960000241
Watch 10
Figure BDA0002436776960000242
Figure BDA0002436776960000251
TABLE 11
Figure BDA0002436776960000252
Example 3 analysis of results
By comparing the detection method of 57 Vibrio parahaemolyticus K antigen genotypes of example 2 with the conventional serological method, with reference to the serological method, the fluorescence probe melting curve method as described in example 2 of Table 12 below has a sensitivity of 100%, a specificity of 100% and a Kappa value of more than 0.75 of 1.0. This indicates that the fluorescent probe melting curve method has excellent consistency with the conventional serum method, i.e., the "fluorescent probe melting curve method" described in example 2 can be used as a rapid typing molecular identification method for the K antigen of Vibrio parahaemolyticus.
TABLE 12
Figure BDA0002436776960000253
Figure BDA0002436776960000261
Note: sensitivity of the fluorescence probe melting curve method: A/(A + C). times.100%. 100%
Specificity of the fluorescence probe melting curve method: D/(B + D). times.100%: 100%
Coincidence rate of the fluorescent probe melting curve method: (A + D)/(A + B + C + D). times.100% -100%
Kappa-Pe)/(1-Pe-1 of the fluorescence probe melting curve method
Therefore, the primer group for detecting K antigen genotyping of Vibrio parahaemolyticus provided by the invention is based on a fluorescent probe melting curve technology of multiple hybridization connection reaction, biological informatics method analysis is carried out according to the whole genome of 418 strains of Vibrio parahaemolyticus, 18 strains of Vibrio parahaemolyticus specific gene sequences in a public database are analyzed, specific genes and specific gene regions of 57 types of K antigens of Vibrio parahaemolyticus are obtained and screened, the obtained specific genes of 57 types of K antigens of Vibrio parahaemolyticus are designed, the primer group can be ensured to simultaneously detect the K antigen genotyping of 57 types of Vibrio parahaemolyticus based on the fluorescent probe melting curve method, the detection time and the detection accuracy of the antigen genotyping of Vibrio parahaemolyticus are improved, and meanwhile, higher sensitivity and specificity can be ensured.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.
SEQUENCE LISTING
<110> Shenzhen disease prevention and control center
<120> primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus
<130> 2020-3-6
<160> 140
<170> PatentIn version 3.3
<210> 1
<211> 82
<212> DNA
<213> Artificial Synthesis
<400> 1
gtggcagggc gctacgaaca atcctaacga ctctatctgc ttgttagtga cgatgggatt 60
agctatacct aggctagccg gt 82
<210> 2
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 2
gctcatggag accctaacta taactcagtt gagattggat cttgctgggc 50
<210> 3
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 3
gtggcagggc gctacgaaca atcctatcgg tccttcatcg ctcagccttc accggttctt 60
gctgacgatc tatgtgttaa cgtag 85
<210> 4
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 4
atggtgatgg cgttcttcag cagatggtga tgagattgga tcttgctggg c 51
<210> 5
<211> 81
<212> DNA
<213> Artificial Synthesis
<400> 5
gtggcagggc gctacgaaca atcctaacga ctatggcttc tcgttggtga cgttggtatt 60
ggtgttgact acggatatgg t 81
<210> 6
<211> 52
<212> DNA
<213> Artificial Synthesis
<400> 6
gctccaagaa tgcaaggttt tctgagtgaa ctgagattgg atcttgctgg gc 52
<210> 7
<211> 86
<212> DNA
<213> Artificial Synthesis
<400> 7
gtggcagggc gctacgaaca atcctacggt gaggaccttt gcagattggc atcaccccgg 60
aaggctgtcg ctctacttct atatcg 86
<210> 8
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 8
agatgagcca acatttatta gttcgggttt gagattggat cttgctgggc 50
<210> 9
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 9
gtggcagggc gctacgaaca atcctaacga ctctggctgc tcgttcgtga cgccgttaga 60
acctaagtct aattatgcag tca 83
<210> 10
<211> 54
<212> DNA
<213> Artificial Synthesis
<400> 10
ctgggctata tttctatgac agtcgcgtaa tagtgagatt ggatcttgct gggc 54
<210> 11
<211> 82
<212> DNA
<213> Artificial Synthesis
<400> 11
gtggcagggc gctacgaaca atcctaacga ctctggctgc tcgttcgtga cgatcttatc 60
gagtcaacag ctatgtatgc ga 82
<210> 12
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 12
gacttagtta cttctactat ggcgatggtt tggagtgaga ttggatcttg ctgggc 56
<210> 13
<211> 82
<212> DNA
<213> Artificial Synthesis
<400> 13
gtggcagggc gctacgaaca atcctaacga ctctagctgc tcgttcgtga cggaacttga 60
ttgaagcaag ggaacattct tt 82
<210> 14
<211> 52
<212> DNA
<213> Artificial Synthesis
<400> 14
cggtgagtat gatttaatac attgtcactt ctgagattgg atcttgctgg gc 52
<210> 15
<211> 86
<212> DNA
<213> Artificial Synthesis
<400> 15
gtggcagggc gctacgaaca atcctatcgg tcctttatcg ctcacccttc accggcggag 60
tgattataag gaggagtgct ataatg 86
<210> 16
<211> 49
<212> DNA
<213> Artificial Synthesis
<400> 16
tgggttcggg aatcggtgtc agtgttaatg agattggatc ttgctgggc 49
<210> 17
<211> 88
<212> DNA
<213> Artificial Synthesis
<400> 17
gtggcagggc gctacgaaca atcctacggt gaagcccttg gcaggtcggt atcacccggt 60
tcggttaaga taagtacttt gggtagat 88
<210> 18
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 18
gtttcattgc actcgctctg cttattacgt gagattggat cttgctgggc 50
<210> 19
<211> 86
<212> DNA
<213> Artificial Synthesis
<400> 19
gtggcagggc gctacgaaca atcctatcgc tccttcatag ctcagacttc atcgggaact 60
agtaagttta tataacccgg cattgc 86
<210> 20
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 20
attgtattga agagcaacgt gattttcctc aatcgtgaga ttggatcttg ctgggc 56
<210> 21
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 21
gtggcagggc gctacgaaca atcctatcgc tccttcatag ctcagacttc atcgggacct 60
cttggatggg attctaatat acacg 85
<210> 22
<211> 54
<212> DNA
<213> Artificial Synthesis
<400> 22
ataagtttga taaagtattc acttggagca ctctgagatt ggatcttgct gggc 54
<210> 23
<211> 79
<212> DNA
<213> Artificial Synthesis
<400> 23
gtggcagggc gctacgaaca atcctaacga ctctagcttc tcgttagtga cgacaggaca 60
tacccaaaag acattggca 79
<210> 24
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 24
ctggctggac tggaacccag ttcttcatgt gagattggat cttgctgggc 50
<210> 25
<211> 81
<212> DNA
<213> Artificial Synthesis
<400> 25
gtggcagggc gctacgaaca atcctaacga ctctagcttc tcgttagtga cggcttcttg 60
accacacgtt attgtaccaa t 81
<210> 26
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 26
ctttgctagg tacaaagcca aaagcagcca tgagattgga tcttgctggg c 51
<210> 27
<211> 82
<212> DNA
<213> Artificial Synthesis
<400> 27
gtggcagggc gctacgaaca atcctacggt gaagccattg ccaggtggta tacccgagtt 60
ggcattgatg ctcatctctc ct 82
<210> 28
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 28
atctattctg ttataaaatt gagtgtctac ggacgtgaga ttggatcttg ctgggc 56
<210> 29
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 29
gtggcagggc gctacgaaca atcctaacga ctctagcttc tcgttagtga cggatatgca 60
agacttgcaa aagctcatca caa 83
<210> 30
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 30
aatcatctag gttgatgtgg gctctttgtt gagattggat cttgctgggc 50
<210> 31
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 31
gtggcagggc gctacgaaca atcctaacga cactggctgc tggtccgtga cggcactgaa 60
tacgccttaa aaactctaat agc 83
<210> 32
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 32
ttgggcttca gttgttgcaa ctattggtgt tgagattgga tcttgctggg c 51
<210> 33
<211> 87
<212> DNA
<213> Artificial Synthesis
<400> 33
gtggcagggc gctacgaaca atcctacggt gaggaccttt gcagattggc atcacccgtt 60
agctgtggaa gacgtgtatt gtttgaa 87
<210> 34
<211> 55
<212> DNA
<213> Artificial Synthesis
<400> 34
aactgtaaca acgacataat gatactattc gatgtgagat tggatcttgc tgggc 55
<210> 35
<211> 84
<212> DNA
<213> Artificial Synthesis
<400> 35
gtggcagggc gctacgaaca atcctaacga ctatggcttc tcgttggtga cgtttcgaca 60
atccaatttc tgagcgagtc ttta 84
<210> 36
<211> 52
<212> DNA
<213> Artificial Synthesis
<400> 36
ccttcattta tgcgtttaca aatccatcta ctgagattgg atcttgctgg gc 52
<210> 37
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 37
gtggcagggc gctacgaaca atcctatcgg tccttcatcg ctcagccttc accggcgaaa 60
ttcatagcga tcttgagact ttcaa 85
<210> 38
<211> 52
<212> DNA
<213> Artificial Synthesis
<400> 38
tcttggttgt aggaatttat gccatatacc atgagattgg atcttgctgg gc 52
<210> 39
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 39
gtggcagggc gctacgaaca atcctaacga ctctagctgc tcgttcgtga cgcttacacg 60
caattttaga ggcgttacaa tat 83
<210> 40
<211> 55
<212> DNA
<213> Artificial Synthesis
<400> 40
ctgctattgg tattgggatt gcactatctc tagctgagat tggatcttgc tgggc 55
<210> 41
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 41
gtggcagggc gctacgaaca atcctaacga ctctgtcttc tcgttcgtga cggcttatct 60
agtcgttctt catttggtga gaaag 85
<210> 42
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 42
ctttcaactc caaaagtatc gtgattagaa tgagattgga tcttgctggg c 51
<210> 43
<211> 84
<212> DNA
<213> Artificial Synthesis
<400> 43
gtggcagggc gctacgaaca atcctatccg ttctttatcg ctcagccttc atcggccata 60
ttttgaccct tcagttaggt atcg 84
<210> 44
<211> 55
<212> DNA
<213> Artificial Synthesis
<400> 44
ttgtttcaat cttgctgatg agctaaatga gcgatgagat tggatcttgc tgggc 55
<210> 45
<211> 84
<212> DNA
<213> Artificial Synthesis
<400> 45
gtggcagggc gctacgaaca atcctaacga ctctagctgc ttgttcgtga cgtgataagt 60
attctttgat atcgaaagtg gcga 84
<210> 46
<211> 52
<212> DNA
<213> Artificial Synthesis
<400> 46
gtgtttacaa taagaagatt aaaattgaga gtgagattgg atcttgctgg gc 52
<210> 47
<211> 88
<212> DNA
<213> Artificial Synthesis
<400> 47
gtggcagggc gctacgaaca atcctacggt gaggaccttt gccgattggc atcacccatt 60
caagtcatgg attactggtc cttgtatt 88
<210> 48
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 48
ttgatcggtg ctggttggtg gcagtatggt gagattggat cttgctgggc 50
<210> 49
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 49
gtggcagggc gctacgaaca atcctatcgg tccttcatcg ctcggccttc accggttggg 60
tatgcttccg tcatttagaa ctatt 85
<210> 50
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 50
cactacggag atacagccaa ctactatgac tgagattgga tcttgctggg c 51
<210> 51
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 51
gtggcagggc gctacgaaca atcctatcgg tcctttatcg ctcacccttc accggccaat 60
cgatgaacca aattaggcaa tttgc 85
<210> 52
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 52
tgcaatcgct gtgtcacttt ttgccttgct tgagattgga tcttgctggg c 51
<210> 53
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 53
gtggcagggc gctacgaaca atcctatcgg tccttcatgg ctcagtcttc accggggtat 60
tggattgcag ttagatgcgg agtaa 85
<210> 54
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 54
cgaagcttca tatcaccggg atgcaaagat gagattggat cttgctgggc 50
<210> 55
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 55
gtggcagggc gctacgaaca atcctaacga ctctagctgc tcgttcgtga cgctcacaat 60
tgtaagacga ttactttaca gca 83
<210> 56
<211> 53
<212> DNA
<213> Artificial Synthesis
<400> 56
cggattgtat gttgattact cattaagtga aatgagattg gatcttgctg ggc 53
<210> 57
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 57
gtggcagggc gctacgaaca atcctatcgg tccttcatcg ctcggccttc accggattgg 60
caaaaaaggt ttgtttcaat cgaat 85
<210> 58
<211> 55
<212> DNA
<213> Artificial Synthesis
<400> 58
ctagcaatkt ggctctaagt rgtttgaatg taggtgagat tggatcttgc tgggc 55
<210> 59
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 59
gtggcagggc gctacgaaca atcctatccg ttctttatcg ctcagccttc atcggagatt 60
ctgacctcta tgggaaaggg tat 83
<210> 60
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 60
gggttagggt ggtccttatt tagtgatttt gagattggat cttgctgggc 50
<210> 61
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 61
gtggcagggc gctacgaaca atcctatcgc tccttcatag ctcagacttc atcggggtat 60
cgccgttact ggcacatacc atg 83
<210> 62
<211> 52
<212> DNA
<213> Artificial Synthesis
<400> 62
attattgtcc gctatctgtt gactttggga ttgagattgg atcttgctgg gc 52
<210> 63
<211> 84
<212> DNA
<213> Artificial Synthesis
<400> 63
gtggcagggc gctacgaaca atcctaacga ctctatctgc ttgttagtga cggtggtagg 60
ttctttgcat acatactgct cctg 84
<210> 64
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 64
aacgattctg tgtttcgtac aacttatatg gtgtatgaga ttggatcttg ctgggc 56
<210> 65
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 65
gtggcagggc gctacgaaca atcctaacga ctctagctgc ttgttcgtga cgatgatagc 60
aaagatgtcg ctcatataac gag 83
<210> 66
<211> 55
<212> DNA
<213> Artificial Synthesis
<400> 66
ttgggagatg gggtttcaag cattatttag agtttgagat tggatcttgc tgggc 55
<210> 67
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 67
gtggcagggc gctacgaaca atcctacggt gaggcccttg gcaggttgct atcacccaaa 60
caaagctctc aaggatgcta agctt 85
<210> 68
<211> 54
<212> DNA
<213> Artificial Synthesis
<400> 68
gatggtgcga gtatttttat tatatcgggt ggatgagatt ggatcttgct gggc 54
<210> 69
<211> 88
<212> DNA
<213> Artificial Synthesis
<400> 69
gtggcagggc gctacgaaca atcctacggt gcggaccttt gccgattggc atcaccctgt 60
aactctaaac ctaagtcttc atggctga 88
<210> 70
<211> 54
<212> DNA
<213> Artificial Synthesis
<400> 70
tgttttgttt tgcggtattg tcacaaaact cagtgagatt ggatcttgct gggc 54
<210> 71
<211> 82
<212> DNA
<213> Artificial Synthesis
<400> 71
gtggcagggc gctacgaaca atcctaacga ctctgtcttc tcgttcgtga cgtttgcgtt 60
gtctctattg tattactttg cg 82
<210> 72
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 72
ctatatttcc tagctaagga aatggggcag ataagtgaga ttggatcttg ctgggc 56
<210> 73
<211> 88
<212> DNA
<213> Artificial Synthesis
<400> 73
gtggcagggc gctacgaaca atcctacggt gaggaccttt gccgattggc atcacccgct 60
tttgcaatga taagtaatgc tcaggtaa 88
<210> 74
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 74
tgtatctttc tctacaagaa aatcccttgc ttggatgaga ttggatcttg ctgggc 56
<210> 75
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 75
gtggcagggc gctacgaaca atcctaacga cactggctgc tggtccgtga cgaatactct 60
atgggtggcg atatattgcg ata 83
<210> 76
<211> 54
<212> DNA
<213> Artificial Synthesis
<400> 76
ggctatggcg ggattgatgc aagtgcttat aagtgagatt ggatcttgct gggc 54
<210> 77
<211> 88
<212> DNA
<213> Artificial Synthesis
<400> 77
gtggcagggc gctacgaaca atcctacggt gaggaccttt gccgattggc atcaccctgc 60
agcactctct tgattacagt gatgatta 88
<210> 78
<211> 54
<212> DNA
<213> Artificial Synthesis
<400> 78
cggtctcgca tcaattctgg ctacttttgc tgctgagatt ggatcttgct gggc 54
<210> 79
<211> 87
<212> DNA
<213> Artificial Synthesis
<400> 79
gtggcagggc gctacgaaca atcctacggt gcggaccttt gccgattggc atcaccccca 60
gttcgtcttt gaaacgtatt tgccaaa 87
<210> 80
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 80
cgctcttgtt aggcttcctc tcattaattt gagattggat cttgctgggc 50
<210> 81
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 81
gtggcagggc gctacgaaca atcctacggt gaagccattg ccaggtggta tacctgtttg 60
attataaccc ttatggtgcg attct 85
<210> 82
<211> 49
<212> DNA
<213> Artificial Synthesis
<400> 82
ggggttaggt tcaatggggt tgtatgaatg agattggatc ttgctgggc 49
<210> 83
<211> 86
<212> DNA
<213> Artificial Synthesis
<400> 83
gtggcagggc gctacgaaca atcctacggt gaggaccttt gcagattggc atcacccatg 60
catttaaagg agttacaacc actcca 86
<210> 84
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 84
caggctctgg cctcgcttat tattttaggt gagattggat cttgctgggc 50
<210> 85
<211> 86
<212> DNA
<213> Artificial Synthesis
<400> 85
gtggcagggc gctacgaaca atcctacggt gaagcccttc gcaggtcggt atcacccagc 60
tatctgatga ccttgtggca tttaaa 86
<210> 86
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 86
gaaatggttt ctaaagtagt tcctattgtc gcctttgaga ttggatcttg ctgggc 56
<210> 87
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 87
gtggcagggc gctacgaaca atcctacggt gaggcccttg gcaggttgct atcacccatg 60
gtgaattctg ggtaagaaac aaccg 85
<210> 88
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 88
tacgagtctt tgggggcaat atgtattttc agctctgaga ttggatcttg ctgggc 56
<210> 89
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 89
gtggcagggc gctacgaaca atcctacggt gaagccattg ccaggtggta taccctgtca 60
gactccggaa ttcccgcttt atcat 85
<210> 90
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 90
ctataaagac tttgctctac gattcaagta attcgtgaga ttggatcttg ctgggc 56
<210> 91
<211> 82
<212> DNA
<213> Artificial Synthesis
<400> 91
gtggcagggc gctacgaaca atcctaacga ctctagctgc ttgttcgtga cggctaattc 60
tcaatcaaat ggatgggact gg 82
<210> 92
<211> 54
<212> DNA
<213> Artificial Synthesis
<400> 92
tattcataca aagattcgtt cgagcaaatt tcttgagatt ggatcttgct gggc 54
<210> 93
<211> 82
<212> DNA
<213> Artificial Synthesis
<400> 93
gtggcagggc gctacgaaca atcctaacga cactggctgc tggtccgtga cgtagaacac 60
tcaaaccgga agttcatcgc aa 82
<210> 94
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 94
gaatggatgc tgatgatatt tcagagccat gagattggat cttgctgggc 50
<210> 95
<211> 89
<212> DNA
<213> Artificial Synthesis
<400> 95
gtggcagggc gctacgaaca atcctacggt gcggaccttt gccgattggc atcacccacg 60
acgagtgttc aattggatga cgatagttc 89
<210> 96
<211> 57
<212> DNA
<213> Artificial Synthesis
<400> 96
aatgtttatc tctctactaa acggagagtt taggagtgag attggatctt gctgggc 57
<210> 97
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 97
gtggcagggc gctacgaaca atcctacggt gaagcccttc gcaggtcggt atcacccctt 60
cttgttacag cctttaagag cggga 85
<210> 98
<211> 49
<212> DNA
<213> Artificial Synthesis
<400> 98
ttggtgccat tttcatccgg atttggtgtg agattggatc ttgctgggc 49
<210> 99
<211> 80
<212> DNA
<213> Artificial Synthesis
<400> 99
gtggcagggc gctacgaaca atcctaacga ctctgtcttc tcgttcgtga cgcgctaaag 60
ggtggggaga taacgggata 80
<210> 100
<211> 53
<212> DNA
<213> Artificial Synthesis
<400> 100
ggaatacatc aaactggtgg gctagataat cgtgagattg gatcttgctg ggc 53
<210> 101
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 101
gtggcagggc gctacgaaca atcctacggt gaagcccttg gcaggtcggt atcacccaag 60
cctttcagcc atccccaaga atcca 85
<210> 102
<211> 53
<212> DNA
<213> Artificial Synthesis
<400> 102
cctgttcttg gagagttaag accatcaata cttgagattg gatcttgctg ggc 53
<210> 103
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 103
gtggcagggc gctacgaaca atcctaacga ctctggctgc tcgttcgtga cgaacaaaga 60
ttccttccgg agataaatat tcc 83
<210> 104
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 104
attcctggta tatctggcgt ttcggctgta tgagattgga tcttgctggg c 51
<210> 105
<211> 88
<212> DNA
<213> Artificial Synthesis
<400> 105
gtggcagggc gctacgaaca atcctacggt gaagcccttc gcaggtcggt atcaccctat 60
ggacgcagtc gcgcaatgat gttttgca 88
<210> 106
<211> 56
<212> DNA
<213> Artificial Synthesis
<400> 106
ctgcaattat attatttatg acagcttccg ttctctgaga ttggatcttg ctgggc 56
<210> 107
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 107
gtggcagggc gctacgaaca atcctaacga ctatggcttc tcgttggtga cgcgatacta 60
atgactcaga tgtatgccca ggatt 85
<210> 108
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 108
tttacagaaa tgtggggcca agaaagttat gagattggat cttgctgggc 50
<210> 109
<211> 85
<212> DNA
<213> Artificial Synthesis
<400> 109
gtggcagggc gctacgaaca atcctacggt gaagcccttg gcaggtcggt atcacccgta 60
gtccttgcat accccgtgtt aatag 85
<210> 110
<211> 50
<212> DNA
<213> Artificial Synthesis
<400> 110
tatctgccgg attgctcagg aatggacaat gagattggat cttgctgggc 50
<210> 111
<211> 83
<212> DNA
<213> Artificial Synthesis
<400> 111
gtggcagggc gctacgaaca atcctaacga ctctatctgc ttgttagtga cgatacacaa 60
tcgttcaaca taataaggca agc 83
<210> 112
<211> 55
<212> DNA
<213> Artificial Synthesis
<400> 112
actagggatg gcaatttgtc tttattcgct ggactgagat tggatcttgc tgggc 55
<210> 113
<211> 87
<212> DNA
<213> Artificial Synthesis
<400> 113
gtggcagggc gctacgaaca atcctacggt gaggcccttg gcaggttgct atcacccgga 60
attgaagtat gtttctttga agaggga 87
<210> 114
<211> 51
<212> DNA
<213> Artificial Synthesis
<400> 114
ccatgctttt atcgtgcagg acaaactaag tgagattgga tcttgctggg c 51
<210> 115
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 115
acgactctgg ctgctcgttc gtgacg 26
<210> 116
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 116
acgactctag ctgctcgttc gtgacg 26
<210> 117
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 117
acgactctgt cttctcgttc gtgacg 26
<210> 118
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 118
acgactctag ctgcttgttc gtgacg 26
<210> 119
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 119
acgacactgg ctgctggtcc gtgacg 26
<210> 120
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 120
acgactctag cttctcgtta gtgacg 26
<210> 121
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 121
acgactatgg cttctcgttg gtgacg 26
<210> 122
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 122
acgactctat ctgcttgtta gtgacg 26
<210> 123
<211> 31
<212> DNA
<213> Artificial Synthesis
<400> 123
cggtgaggcc cttggcaggt tgctatcacc c 31
<210> 124
<211> 31
<212> DNA
<213> Artificial Synthesis
<400> 124
cggtgaagcc cttggcaggt cggtatcacc c 31
<210> 125
<211> 31
<212> DNA
<213> Artificial Synthesis
<400> 125
cggtgaagcc cttcgcaggt cggtatcacc c 31
<210> 126
<211> 31
<212> DNA
<213> Artificial Synthesis
<400> 126
cggtgaggac ctttgcagat tggcatcacc c 31
<210> 127
<211> 31
<212> DNA
<213> Artificial Synthesis
<400> 127
cggtgaggac ctttgccgat tggcatcacc c 31
<210> 128
<211> 31
<212> DNA
<213> Artificial Synthesis
<400> 128
cggtgcggac ctttgccgat tggcatcacc c 31
<210> 129
<211> 28
<212> DNA
<213> Artificial Synthesis
<400> 129
cggtgaagcc attgccaggt ggtatacc 28
<210> 130
<211> 29
<212> DNA
<213> Artificial Synthesis
<400> 130
tcggtccttc atcgctcagc cttcaccgg 29
<210> 131
<211> 29
<212> DNA
<213> Artificial Synthesis
<400> 131
tcggtccttc atcgctcggc cttcaccgg 29
<210> 132
<211> 29
<212> DNA
<213> Artificial Synthesis
<400> 132
tcggtccttt atcgctcacc cttcaccgg 29
<210> 133
<211> 29
<212> DNA
<213> Artificial Synthesis
<400> 133
tcggtccttc atggctcagt cttcaccgg 29
<210> 134
<211> 29
<212> DNA
<213> Artificial Synthesis
<400> 134
tccgttcttt atcgctcagc cttcatcgg 29
<210> 135
<211> 29
<212> DNA
<213> Artificial Synthesis
<400> 135
tcgctccttc atagctcaga cttcatcgg 29
<210> 136
<211> 22
<212> DNA
<213> Artificial Synthesis
<400> 136
gtggcagggc gctacgaaca at 22
<210> 137
<211> 21
<212> DNA
<213> Artificial Synthesis
<400> 137
gcccagcaag atccaatctc a 21
<210> 138
<211> 26
<212> DNA
<213> Artificial Synthesis
<400> 138
acgactctgg ctgctcgttc gtgacg 26
<210> 139
<211> 29
<212> DNA
<213> Artificial Synthesis
<400> 139
tcggtccttc atcgctcagc cttcaccgg 29
<210> 140
<211> 31
<212> DNA
<213> Artificial Synthesis
<400> 140
cggtgaggcc cttggcaggt tgctatcacc c 31

Claims (3)

1. A method for detecting K antigen genotyping of Vibrio parahaemolyticus, which is not disease treatment or diagnosis, comprising the steps of:
dividing the hybridization connection primers of 57 vibrio parahaemolyticus K antigen genes into 3 tubes, and simultaneously carrying out detection in the following steps; wherein the hybridization connecting primer group comprises: the 1 st tube is a first hybridization connecting primer group for genotyping twenty one antigen of K70, K68, K17, K56, K29, K25, K8, K6, K18, K42, K44, K5, K60, K11, K41, K12, K28, K13, K9, K36 and K3; the 2 nd tube is a second hybridization connecting primer group for genotyping twenty one antigens, namely K1, K4, K19, K20, K55, K63, K34, K65, K49, K48, K30, K21, K67, K69, K71, K38, K37, K33, K32, K31 and K23; the 3 rd tube is a third hybridization connecting primer group for fifteen types of antigen genotyping of K39, K22, K15, K45, K40, K43, K24, K7, K54, K59, K46, K51, K52, K64 and K53;
mixing the first hybridization connection primer group, the second hybridization connection primer group and the third hybridization connection primer group with a vibrio parahaemolyticus DNA template respectively, and performing first denaturation treatment to obtain a primer group mixed solution;
mixing the primer group mixed solution with ligase and a ligase buffer solution, and carrying out a hybridization ligation reaction to obtain a hybridization ligation product;
mixing the hybridization ligation product with PCR buffer solution and MgCl2dNTP, rTaq enzyme, an upstream universal primer, a downstream universal primer and a fluorescent probe are mixed to perform a fluorescent probe melting curve method PCR amplification reaction, perform a fluorescent probe melting curve method fluorescence analysis reaction, and detect the K antigen genotyping of vibrio parahaemolyticus;
wherein the hybridization connecting primer group comprises:
hybrid connecting primers SEQ ID No.1 and SEQ ID No.2 for detecting K1 antigen genotyping;
hybrid connecting primers SEQ ID No.3 and SEQ ID No.4 for detecting K3 antigen genotyping;
hybrid connecting primers SEQ ID No.5 and SEQ ID No.6 for detecting K4 antigen genotyping;
hybrid connecting primers SEQ ID No.7 and SEQ ID No.8 for detecting K5 antigen genotyping;
hybrid connecting primers SEQ ID No.9 and SEQ ID No.10 for detecting K6 antigen genotyping;
hybrid connecting primers SEQ ID No.11 and SEQ ID No.12 for detecting K7 antigen genotyping;
hybrid connecting primers SEQ ID No.13 and SEQ ID No.14 for detecting K8 antigen genotyping;
hybrid connecting primers SEQ ID No.15 and SEQ ID No.16 for detecting K9 antigen genotyping;
hybrid connecting primers SEQ ID No.17 and SEQ ID No.18 for detecting K11 antigen genotyping;
hybrid connecting primers SEQ ID No.19 and SEQ ID No.20 for detecting K12 antigen genotyping;
hybrid connecting primers SEQ ID No.21 and SEQ ID No.22 for detecting K13 antigen genotyping;
hybrid connecting primers SEQ ID No.23 and SEQ ID No.24 for detecting K15 antigen genotyping;
hybrid connecting primers SEQ ID No.25 and SEQ ID No.26 for detecting K17 antigen genotyping;
hybrid connecting primers SEQ ID No.27 and SEQ ID No.28 for detecting K18 antigen genotyping;
hybrid connecting primers SEQ ID No.29 and SEQ ID No.30 for detecting K19 antigen genotyping;
hybrid connecting primers SEQ ID No.31 and SEQ ID No.32 for detecting K20 antigen genotyping;
hybrid connecting primers SEQ ID No.33 and SEQ ID No.34 for detecting K21 antigen genotyping;
hybrid connecting primers SEQ ID No.35 and SEQ ID No.36 for detecting K22 antigen genotyping;
hybrid connecting primers SEQ ID No.37 and SEQ ID No.38 for detecting K23 antigen genotyping;
hybrid connecting primers SEQ ID No.39 and SEQ ID No.40 for detecting K24 antigen genotyping;
hybrid connecting primers SEQ ID No.41 and SEQ ID No.42 for detecting K25 antigen genotyping;
hybrid connecting primers SEQ ID No.43 and SEQ ID No.44 for detecting K28 antigen genotyping;
hybrid connecting primers SEQ ID No.45 and SEQ ID No.46 for detecting K29 antigen genotyping;
hybrid connecting primers SEQ ID No.47 and SEQ ID No.48 for detecting K30 antigen genotyping;
hybrid connecting primers SEQ ID No.49 and SEQ ID No.50 for detecting K31 antigen genotyping;
hybrid connecting primers SEQ ID No.51 and SEQ ID No.52 for detecting K32 antigen genotyping;
hybrid connecting primers SEQ ID No.53 and SEQ ID No.54 for detecting K33 antigen genotyping;
hybrid connecting primers SEQ ID No.55 and SEQ ID No.56 for detecting K34 antigen genotyping;
hybrid connecting primers SEQ ID No.57 and SEQ ID No.58 for detecting K36 antigen genotyping;
hybrid connecting primers SEQ ID No.59 and SEQ ID No.60 for detecting K37 antigen genotyping;
hybrid connecting primers SEQ ID No.61 and SEQ ID No.62 for detecting K38 antigen genotyping;
hybrid connecting primers SEQ ID No.63 and SEQ ID No.64 for detecting K39 antigen genotyping;
hybrid connecting primers SEQ ID No.65 and SEQ ID No.66 for detecting K40 antigen genotyping;
hybrid connecting primers SEQ ID No.67 and SEQ ID No.68 for detecting K41 antigen genotyping;
hybrid connecting primers SEQ ID No.69 and SEQ ID No.70 for detecting K42 antigen genotyping;
hybrid connecting primers SEQ ID No.71 and SEQ ID No.72 for detecting K43 antigen genotyping;
hybrid connecting primers SEQ ID No.73 and SEQ ID No.74 for detecting K44 antigen genotyping;
hybrid connecting primers SEQ ID No.75 and SEQ ID No.76 for detecting K45 antigen genotyping;
hybrid connecting primers SEQ ID No.77 and SEQ ID No.78 for detecting K46 antigen genotyping;
hybrid connecting primers SEQ ID No.79 and SEQ ID No.80 for detecting K48 antigen genotyping;
hybrid connecting primers SEQ ID No.81 and SEQ ID No.82 for detecting K49 antigen genotyping;
hybrid connecting primers SEQ ID No.83 and SEQ ID No.84 for detecting K51 antigen genotyping;
hybrid connecting primers SEQ ID No.85 and SEQ ID No.86 for detecting K52 antigen genotyping;
hybrid connecting primers SEQ ID No.87 and SEQ ID No.88 for detecting K53 antigen genotyping;
hybrid connecting primers SEQ ID No.89 and SEQ ID No.90 for detecting K54 antigen genotyping;
hybrid connecting primers SEQ ID No.91 and SEQ ID No.92 for detecting K55 antigen genotyping;
hybrid connecting primers SEQ ID No.93 and SEQ ID No.94 for detecting K56 antigen genotyping;
hybrid connecting primers SEQ ID No.95 and SEQ ID No.96 for detecting K59 antigen genotyping;
hybrid connecting primers SEQ ID No.97 and SEQ ID No.98 for detecting K60 antigen genotyping;
hybrid connecting primers SEQ ID No.99 and SEQ ID No.100 for detecting K63 antigen genotyping;
hybrid connecting primers SEQ ID No.101 and SEQ ID No.102 for detecting K64 antigen genotyping;
hybrid connecting primers SEQ ID No.103 and SEQ ID No.104 for detecting K65 antigen genotyping;
hybrid connecting primers SEQ ID No.105 and SEQ ID No.106 for detecting K67 antigen genotyping;
hybrid connecting primers SEQ ID No.107 and SEQ ID No.108 for detecting K68 antigen genotyping;
hybrid connecting primers SEQ ID No.109 and SEQ ID No.110 for detecting K69 antigen genotyping;
hybrid connecting primers SEQ ID No.111 and SEQ ID No.112 for detecting K70 antigen genotyping;
hybrid connecting primers SEQ ID No.113 and SEQ ID No.114 for detecting K71 antigen genotyping;
in each tube, the Tm temperature peaks of the melting point signatures for antigen genotyping are as follows:
in the ROX fluorescence channel of the 1 st tube, the Tm temperature peak value of K70 antigen is 50.5 ℃, the Tm temperature peak value of K68 antigen is 54.0 ℃, the Tm temperature peak value of K17 antigen is 57.5 ℃, the Tm temperature peak value of K56 antigen is 60.0 ℃, the Tm temperature peak value of K29 antigen is 63.5 ℃, the Tm temperature peak value of K25 antigen is 66.5 ℃, the Tm temperature peak value of K8 antigen is 70.0 ℃, and the Tm temperature peak value of K6 antigen is 74.5 ℃;
in a Cy5 fluorescence channel of a tube 1, the Tm temperature peak value of K18 antigen is 53.5 ℃, the Tm temperature peak value of K42 antigen is 56.0 ℃, the Tm temperature peak value of K44 antigen is 58.5 ℃, the Tm temperature peak value of K5 antigen is 61.0 ℃, the Tm temperature peak value of K60 antigen is 66.0 ℃, the Tm temperature peak value of K11 antigen is 70.5 ℃, and the Tm temperature peak value of K41 antigen is 74.0 ℃;
in the FAM fluorescence channel of the 1 st tube, the Tm temperature peak value of K12 antigen is 51.0 ℃, the Tm temperature peak value of K28 antigen is 57.0 ℃, the Tm temperature peak value of K13 antigen is 61.5 ℃, the Tm temperature peak value of K9 antigen is 66.0 ℃, the Tm temperature peak value of K36 antigen is 70.0 ℃, and the Tm temperature peak value of K3 antigen is 74.5 ℃;
in the ROX fluorescence channel of the 2 nd tube, the Tm temperature peak value of K1 antigen is 51.0 ℃, the Tm temperature peak value of K4 antigen is 54.0 ℃, the Tm temperature peak value of K19 antigen is 57.0 ℃, the Tm temperature peak value of K20 antigen is 59.0 ℃, the Tm temperature peak value of K55 antigen is 62.5 ℃, the Tm temperature peak value of K63 antigen is 66.5 ℃, the Tm temperature peak value of K34 antigen is 70.0 ℃, and the Tm temperature peak value of K65 antigen is 73.5 ℃;
in a Cy5 fluorescence channel of a tube 2, the Tm temperature peak value of K49 antigen is 50.5 ℃, the Tm temperature peak value of K48 antigen is 55.5 ℃, the Tm temperature peak value of K30 antigen is 58.5 ℃, the Tm temperature peak value of K21 antigen is 61.5 ℃, the Tm temperature peak value of K67 antigen is 66.0 ℃, the Tm temperature peak value of K69 antigen is 70.5 ℃, and the Tm temperature peak value of K71 antigen is 74.5 ℃;
in the FAM fluorescence channel of the 2 nd tube, the Tm temperature peak value of K38 antigen is 52.0 ℃, the Tm temperature peak value of K37 antigen is 57.0 ℃, the Tm temperature peak value of K33 antigen is 61.0 ℃, the Tm temperature peak value of K32 antigen is 65.5 ℃, the Tm temperature peak value of K31 antigen is 69.5 ℃, and the Tm temperature peak value of K23 antigen is 74.0 ℃;
in the ROX fluorescence channel of the 3 rd tube, the Tm temperature peak value of K39 antigen is 50.5 ℃, the Tm temperature peak value of K22 antigen is 54.0 ℃, the Tm temperature peak value of K15 antigen is 57.0 ℃, the Tm temperature peak value of K45 antigen is 59.0 ℃, the Tm temperature peak value of K40 antigen is 62.5 ℃, the Tm temperature peak value of K43 antigen is 66.5 ℃, the Tm temperature peak value of K24 antigen is 70.0 ℃, and the Tm temperature peak value of K7 antigen is 74.0 ℃;
in a Cy5 fluorescence channel of a tube 3, the Tm temperature peak value of K54 antigen is 53.0 ℃, the Tm temperature peak value of K59 antigen is 56.0 ℃, the Tm temperature peak value of K46 antigen is 58.5 ℃, the Tm temperature peak value of K51 antigen is 61.5 ℃, the Tm temperature peak value of K52 antigen is 66.0 ℃, the Tm temperature peak value of K64 antigen is 70.5 ℃, and the Tm temperature peak value of K53 antigen is 74.0 ℃; the upstream universal primer is SEQ ID No. 136; the downstream universal primer is SEQ ID No. 137;
the fluorescent probe is a ROX fluorescent probe, a Cy5 fluorescent probe and a FAM fluorescent probe, and,
the ROX fluorescent probe is SEQ ID No.138, wherein a ROX group is marked at the 5 'end of the sequence of the ROX fluorescent probe, and a BHQ2 group is marked at the 3' end of the sequence of the ROX fluorescent probe;
the FAM fluorescent probe is SEQ ID No.139, wherein a FAM group is marked at the 5 'end of the sequence of the FAM fluorescent probe, and a BHQ1 group is marked at the 3' end of the sequence of the FAM fluorescent probe;
the Cy5 fluorescent probe is SEQ ID No.140, wherein a Cy5 group is marked at the 5 'end of the sequence of the Cy5 fluorescent probe, and a BHQ2 group is marked at the 3' end of the sequence of the Cy5 fluorescent probe.
2. The method for detecting K antigen genotyping of Vibrio parahaemolyticus according to claim 1, wherein the PCR amplification reaction is performed under the following conditions: pre-denaturation at 95 ℃ for 3 min, denaturation at 95 ℃ for 10 sec, annealing at 57 ℃ for 20 sec, extension at 72 ℃ for 20 sec, 38 cycles of reaction set up, and fluorescence signals of ROX, Cy5, FAM were collected at 57 ℃.
3. The method for detecting K antigen genotyping of Vibrio parahaemolyticus according to claim 1, wherein the conditions for performing fluorescence analysis reaction by fluorescence probe melting curve method are as follows: denaturation at 95 ℃ for 1 min, hybridization at 40 ℃ for 2 min, gradual temperature rise from 40 ℃ to 85 ℃, and collection of fluorescence signals of ROX, Cy5, FAM, wherein the fluorescence signals are collected at 0.5 ℃ per rise from 40 ℃ to 85 ℃.
CN202010254527.2A 2020-04-02 2020-04-02 Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus Active CN111411161B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010254527.2A CN111411161B (en) 2020-04-02 2020-04-02 Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010254527.2A CN111411161B (en) 2020-04-02 2020-04-02 Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus

Publications (2)

Publication Number Publication Date
CN111411161A CN111411161A (en) 2020-07-14
CN111411161B true CN111411161B (en) 2021-02-23

Family

ID=71489575

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010254527.2A Active CN111411161B (en) 2020-04-02 2020-04-02 Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus

Country Status (1)

Country Link
CN (1) CN111411161B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11318480A (en) * 1999-04-14 1999-11-24 Toyobo Co Ltd Oligonucleotide for detecting enteritis vibrio and detection of the same vibrio
CN1637152A (en) * 2003-09-05 2005-07-13 东曹株式会社 Detection reagent for thermostable direct hemolysin-related hemolysin gene of vibrio parahaemolyticus
CN1683565A (en) * 2005-03-15 2005-10-19 中国人民解放军军事医学科学院放射医学研究所 Oligonucleotide probe kit for detecting common intestine trac kpathogenic bacteria and its use
CN105154559A (en) * 2015-09-21 2015-12-16 南开大学 Specific nucleotide for vibrio parahaemolyticus K36, K37 and K68 and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11318480A (en) * 1999-04-14 1999-11-24 Toyobo Co Ltd Oligonucleotide for detecting enteritis vibrio and detection of the same vibrio
CN1637152A (en) * 2003-09-05 2005-07-13 东曹株式会社 Detection reagent for thermostable direct hemolysin-related hemolysin gene of vibrio parahaemolyticus
CN1683565A (en) * 2005-03-15 2005-10-19 中国人民解放军军事医学科学院放射医学研究所 Oligonucleotide probe kit for detecting common intestine trac kpathogenic bacteria and its use
CN105154559A (en) * 2015-09-21 2015-12-16 南开大学 Specific nucleotide for vibrio parahaemolyticus K36, K37 and K68 and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Simultaneous Identification of Clinically Common Vibrio parahaemolyticus Serotypes Using Probe Melting Curve Analysis;Mingxu Li等;《Frontiers in cellular and infection Microbiology》;20191114;第9卷;第1-10页 *
副溶血弧菌的致病性检测方法;张金金等;《分子诊断与治疗杂志》;20140731;第6卷(第4期);第274-278页 *

Also Published As

Publication number Publication date
CN111411161A (en) 2020-07-14

Similar Documents

Publication Publication Date Title
CN105624330B (en) 12 boar common virus and bacterium Taqman-MGB PCR kit for fluorescence quantitative and method are detected simultaneously
CN103898208A (en) Quick high-throughput intestines source pathogenic bacterium detection method
US20100075305A1 (en) Detection of bacterium by utilizing dnaj gene and use thereof
CN107988326A (en) Prawn Acute Hepatic pancreatic necrosis(AHPND)RAA constant temperature fluorescence detection method and reagent
CN105018485A (en) Primer and probe for detecting peste des petits ruminants virus by virtue of RPA (Recombinase Polymerase Amplification) technique
CN108504780A (en) 8 kinds of sheep common virus and bacterium Taqman PCR kit for fluorescence quantitative and method are detected simultaneously
CN107988426A (en) Prawn Taura syndrome(TSV)RAA constant temperature fluorescence detection method and reagent
CN1810989B (en) Constant temperature reaction process for detecting DNA and RNA with sequence specificity
CN111004862A (en) Primer and probe for rapidly detecting and identifying cryptococcus and application thereof
CN109777861A (en) The loop-mediated isothermal amplification method of mispairing tolerance and application
CN111411161B (en) Primer group and kit for detecting K antigen genotyping of vibrio parahaemolyticus
CN117144049A (en) Primer probe combination, method and kit for detecting cryptococcus subtype
CN111926110B (en) African swine fever virus real-time fluorescent PCR amplification primer pair, probe primer and prepared kit
CN115786541B (en) SNP molecular marker, primer probe, kit, method and application for identifying Brucella vaccine strain A19
CN111471802A (en) Porcine delta coronavirus rapid detection primer, kit and application thereof
CN103215358A (en) Diarrheogenic escherichia coli detection kit and detection and typing method thereof
CN115747361A (en) Real-time fluorescent MIRA and MIRA-LFD primer group for detecting streptococcus iniae and detection method
CN107385089B (en) Nucleic acid combination, kit and method for detecting cryptosporidium oocysts
CN101235411A (en) Kit for detecting guinea pig aeromonas by utilizing Loop-mediated isothermal amplification technique
KR102276396B1 (en) A composition and RT-qPCR based chip for detecting avian influenza viruses and method for detecting avian influenza viruses using the same
CN113718053A (en) Probe and primer pair for detecting yersinia sporogenes, detection method and application
CN113293231A (en) Real-time fluorescent PCR primer pair and probe set for identifying different genotypes of porcine pseudorabies virus, kit and method
CN106755567B (en) Real-time fluorescence quantitative PCR (polymerase chain reaction) detection primer, probe, detection kit and detection method for simian SRV (sequence-related syndrome Virus)
CN112553350A (en) Method for rapidly detecting multiple mycobacteria
CN112553377A (en) Detection kit for distinguishing Marek&#39;s disease virus vaccine strain and virulent strain by using dual fluorescence LAMP (loop-mediated isothermal amplification) and primer group of detection kit

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant